Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.55 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.55 |
| ▸ | CES2 | O00748 | 1/20 | 0.55 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.55 |
| ▸ | PPARD | Q03181 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | LCK | P06239 | 1/20 | 0.53 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.53 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.52 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.52 |
| ▸ | PPARG | P37231 | 1/20 | 0.52 |
| ▸ | PPARA | Q07869 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9245664 | 1.00 | GPR84 (0.55) | GPR84FFAR1CES2FFAR4PPARD | |
| SCHEMBL6252064 | 1.00 | GPR84 (0.55) | GPR84FFAR1CES2FFAR4PPARD | |
| SCHEMBL17838092 | 1.00 | GPR84 (0.55) | GPR84FFAR1CES2FFAR4PPARD | |
| SCHEMBL6252089 | 1.00 | GPR84 (0.55) | GPR84FFAR1CES2FFAR4PPARD | |
| SCHEMBL2431190 | 1.00 | GPR84 (0.55) | GPR84FFAR1CES2FFAR4PPARD | |
| SCHEMBL18663452 | 1.00 | GPR84 (0.55) | GPR84FFAR1CES2FFAR4PPARD | |
| SCHEMBL10533061 | 1.00 | GPR84 (0.55) | GPR84FFAR1CES2FFAR4PPARD | |
| SCHEMBL350632 | 1.00 | GPR84 (0.55) | GPR84FFAR1CES2FFAR4PPARD | |
| SCHEMBL8482539 | 1.00 | GPR84 (0.55) | GPR84FFAR1CES2FFAR4PPARD | |
| SCHEMBL6250893 | 1.00 | GPR84 (0.55) | GPR84FFAR1CES2FFAR4PPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117778211-A | Fisher-b-schiff yeast (Cyberlindnera fabianii) strain 20, application, product and method thereof | 宁夏农产品质量标准与检测技术研究所(宁夏农产品质量监测中心) | 2024-03-29 | — | — | CN | claimed |
| CN-112773776-B | Drug-loaded nanoparticle system | 上海胜联医药科技有限公司 | 2023-06-20 | — | — | CN | claimed |
| EP-0013949-B1 | DEPOT BODY ON THE BASIS OF SILICON RUBBER AND METHOD FOR ITS PREPARATION | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-06-29 | — | — | EP | claimed |
| CN-113164791-B | Topical antimicrobial microemulsions containing fluorescent substances | 舒万诺知识产权公司 | 2024-05-17 | — | — | CN | disclosed |
| EP-3787752-B1 | HAIRCARE COMPOSITION COMPRISING MODIFIED VEGETABLE WAXES | GATTEFOSSE SAS (FR) | 2024-03-06 | — | — | EP | disclosed |
| CN-116547251-A | Method for manufacturing three-dimensional printing carbon bonding composite product | 法国阿科玛 | 2023-08-04 | — | — | CN | disclosed |
| EP-3787752-A1 | HAIRCARE COMPOSITION COMPRISING MODIFIED VEGETABLE WAXES | GATTEFOSSE SAS (FR) | 2021-03-10 | — | — | EP | disclosed |
| CN-112292132-A | Novel pharmaceutical formulations containing dual NK-1/NK-3 receptor antagonists | KaNDy治疗有限公司 | 2021-01-29 | — | — | CN | disclosed |
| WO-2012063973-A1 | ANTIOXIDANT COMPOSITION COMPRISING OXIDIZED GLUTATHIONE | KYOWA HAKKO BIO CO., LTD. (JP) | 2012-05-18 | — | — | WO | disclosed |
| US-7569231-B2 | Method for stabilizing oil-based thickening gel composition | SHOWA DENKO K.K. (JP) | 2009-08-04 | — | — | US | disclosed |
| US-20070190087-A1 | adding delta -tocopherol to a mixture of anionic surfactant lipopeptide having a cyclic peptide structure and water and/or glycerin; polyoxyethyleneglyceryl ether fatty acid esters and polyoxyethylene sorbitol ether fatty acid esters; storage stability, preventing cosmetic separation of the composition | SHOWA DENKO K.K. (JP) | 2007-08-16 | — | — | US | disclosed |
| EP-1715922-A2 | METHOD FOR STABILIZING OIL-BASED THICKENING GEL COMPOSITION | Showa Denko Kabushiki Kaisha (JP) | 2006-11-02 | — | — | EP | disclosed |
| WO-2005074881-A2 | METHOD FOR STABILIZING OIL-BASED THICKENING GEL COMPOSITION | SHOWA DENKO K.K. (JP) | 2005-08-18 | — | — | WO | disclosed |
| EP-0110278-B1 | PYRAZOLINONES, THEIR PREPARATION AND THEIR USE AS POLYVINYL CHLORIDE POLYMERS STABILIZERS | Henkel Kommanditgesellschaft auf Aktien (DE) | 1987-10-28 | — | — | EP | disclosed |
| EP-0110278-A2 | Pyrazolinones, their preparation and their use as polyvinyl chloride polymers stabilizers | Henkel Kommanditgesellschaft auf Aktien (DE) | 1984-06-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070190087-A1 | adding delta -tocopherol to a mixture of anionic surfactant lipopeptide having a cyclic peptide structure and water and/or glycerin; polyoxyethyleneglyceryl ether fatty acid esters and polyoxyethylene sorbitol ether fatty acid esters; storage stability, preventing cosmetic separation of the composition | DEGS1, TTPA, UGCG | GPR84 930/4885FFAR1 476/4885CES2 2597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.